参考文献/References:
[1]邱敏,颜野,段波,等.一期腹腔镜肾输尿管全长及膀胱切除术的安全性分析.中国微创外科杂志,2018,18(8):686-689.
[2]唐刚,胡海龙,杜智勇,等.上尿路尿路上皮癌根治术后发生慢性肾脏疾病的危险因素分析.中华泌尿外科杂志,2017,38(9):692-697.
[3]Seisen T,Peyronnet B,DominguezEscrig JL,et al.Oncologic outcomes of kidneysparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU nonmuscle invasive bladder cancer guidelines panel.Eur Urol,2016，70(6):1052-1068.
[4]Rouprêt M,Babjuk M,Burger M,et al.European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma:2020 update.Eur Urol,2020，79(1)：62-79.
[5]Wang Q,Zhang T,Wu J,et al.Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.BMC Urol,2019,19(1)：19-24.
[6]Yakoubi R,Colin P,Seisen T,et al.Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma:a metaanalysis and a systematic review of current evidence from comparative studies.Eur J Surg Oncol,2014,40(12):1629-1634.
[7]葛永超,冯金顺,段堃,等.经尿道输尿管下段钬激光切除术治疗肾盂输尿管癌.中国微创外科杂志,2015,15(1):40-46.
[8]Jung H,Giusti G,Fajkovic H,et al.Consultation on UTUC,Stockholm 2018:aspects of treatment.World J Urol,2019,37(11):2279-2287.
[9]Goel MC,Mahendra V,Roberts JG.Percutaneous management of renal pelvic urothelial tumors:longterm followup.J Urol,2003,169(3):925-929.
[10]Fang D,Gong YQ,Singla N,et al.The significance of the initial symptom in Chinese patients with upper tract urothelial carcinoma:regular health examination is still underutilized.Kaohsiung J Med Sci,2018，34(9)：511-521.
[11]袁道彰,都兴华,石利平,等.经腹腹腔镜与后腹腔镜治疗上尿路尿路上皮癌的比较研究.中国微创外科杂志,2016,16(16):812-815.
[12]尚义超,尚攀峰,郑铎,等.不同腹腔镜术式治疗上尿路尿路上皮癌的比较研究.中国微创外科杂志,2021,21(4):293-297.
[13]Chertow GM,Johansen KL,Lew N,et al.Vintage,nutritional status,and survival in hemodialysis patients.Kidney Int,2000,57(3):1176-1181.
[14]Gakis G,Schubert T,Alemozaffar M,et al.Update of the ICUDSIU consultation on upper tract urothelial carcinoma 2016:treatment of lowrisk upper tract urothelial carcinoma.World J Urol,2016,35(3):355-365.
[15]Wang YL,Zhang HL,Du H,et al.Retroperitoneal laparoscopic partial resection of the renal pelvis for urothelial carcinoma:a case report.World J Clin Cases,2021,9(8):1916-1922.
[16]Jacobi CA,Bonjer HJ,Puttick MI,et al.Oncologic implications of laparoscopic and open surgery.Surg Endosc,2002,16(3):441-445.
[17]Wittich P,Steyerberg EW,Simons S,et al.Intraperitoneal tumor growth is influenced by pressure of carbon dioxide pneumoperitoneum.Surg Endosc,2000,14(9):817-819.
[18]Wittich P,Marquet RL,Kazemier G,et al.Portsite metastases after CO2 laparoscopy.Is aerosolization of tumor cells a pivotal factor?Surg Endosc,2000,14(2):189-192.
[19]Micali S,Celia A,Bove P,et al.Tumor seeding in urological laparoscopy:an international survey.J Urol,2004,171(6):2151-2154.
[20]孙颖浩.吴阶平泌尿外科学.北京:人民卫生出版社，2019.792-793.
[21]徐继,喻晓芬,马英玉,等.蒸馏水清除原发性肝癌切除术中腹腔脱落癌细胞的量效关系.中华医学杂志,2016,96(46):3702-3705.
[22]Seisen T,Colin P,Rouprêt M.Riskadapted strategy for the kidneysparing management of upper tract tumours.Nat Rev Urol,2015, 12(3):155-166.